MOORE
MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the benefit of Patients in son￿r$¢t
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024
REGISTERED CHARITY NUMBER 1036580

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the benefit of Pgtients in Somerset
TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024
REFERENCE AND ADMIIYISTRATION DETAILS
CharAty name:
Registered Charity number:
Charity's principal address:
Musgrove Leukaemic Group Som¢rset
1036580
16 Durleigh Road
BRIDGWATER
Somerset
TA6 7HR
Trustees:
Mrs Patricia Reed (Chairperson)
Miss Jane Allin (Secretary)
Mrs Maureen Hudson
Mrs Margaret Smith
Mr Bernard Reed (Treasurer)
Mrs Pat Cornish
Mr David Edwards
Mrs Margaret Edwards (resigned 12.7.23)
Mrs Christine Regan (resigned 12.7.23)
Professional Advisors
Bankers:
National We5tmin5ter Bank plc
26127 Fore Street
TAUNTON
Somerset
Independent Examiner:
Moor¢
Chartered Accountants
6th Floor
Whitefriars
Lewins Mead
Bristol
BSI 2Nr
STRUCTURE GOVERNANCE AND MANAGEMENT
Musgrove Leukaemic Group Somerset is a registered charity and has been constituted as an
unincorporated association governed by a fornial constitution. A copy of the constitution may b¢
obtain¢d on application to the Secretary.
Trustees are elected at each Annual General Meeting but retiring Trustees are eligible for re-
election. Thc oificers may hold office until retirement or by removal at an Annual Gen¢ral
Meeting.
Co-opted Trustees may be appointed by the Committee at any time and generally have special
knowledge or experience with leukaemia or related conditions. They n￿Y serve for such period as
decided by the Committee or by their retirement.

MUSGROVE LEUKAEMIC GROUP SOMERSET
Ralslng funds for the benefit of Padents in Somerset
TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024
(contlnued)
OWECTIVES AND ACTIVITIES
The Charityls Objeclives and activitiesfor the Publlc Benefit
The objects of the Group are to relieve persons suffering from L¢ukaemia and associated conditions
by assisting and funding th¢ tr¢atm¢nts and welfare of such persons at Musgrove Park Hospitsl,
Taunton Somerset or any other area authorised by the medical staff.
The Group carries out these objects by:
Sponsoring the mcdical staff that are LX)nsidered key by the Somerset NHS Foundation Trust to
maintaining Musgrove Park Hospital as a centre for the treatment of Leukaemia and other related
discascs.
The grants made to nursing staff for training are in an aspect which wh¢n complcted will enhance
the experience of Leukaemia patients whilst receiving treatment for Leukaemia and other related
discases.
The purchase of equipment and furniture is made following recomm¢ndations from the medical
staff with a view to improving the quality of th¢ treatsnent and the emotional and physical well-
being of both suffers and relatives.
Chqrity Or8anisa¢lon and History
The Musgrove Leukaemic Group Somerset was launched in 1978 and is nm completely by unpaid
volunteers who absorb all their own personal expense5. There are no paid Officers and overheads
are kept to an absolute minimurn thereby ensuring that most of the funds raised goes to the
Haematology Unit at Musgrove Park Hospital, Taunton. The hospital has beeA)me a major ¢¢ntr¢ in
the South West for the diagnosis and tr￿tsMent of Icukaemia and r¢lat¢d blood disorders.
In general the aims of the Group are as follows:
To maintain Musgrovc Park Hospital as a major centre for the diagnosis and treatment of
leukaemia and related blood disorders by th¢ most up-to-date techniques.
ii)
To keep the public inforn)ed on progress b¢ing made on the diwosis and treatment of these
diseases.
The Group meets regularly in Bridgwat¢r and Taunton.

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the beneflt of Patlents In Somerset
TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024
(continued)
Policy is discussed at both Group and Committcc meetings, but the Committee has the duty to
manage the Group and the power to ultimately make executive decisions.
The Group has area representatives cov¢ring Som¢rsct at Bridgwater, Burnham on Sea, Clwd and
Ilminster, Min¢head. Taunton, and Wellington. The area representatives act as local contacts
organising events and visiting various businesses, people or other organisations as requir¢d. In turn
they report back to Group meetings on a regular basis.
ACHIEVEMENTS AND PERFORMANCE
Chairperson's Report
It is pleasing to report that the Group has been able to recommence fvnding projects at Mus8rove
Park Hospital now that the restrictions imposed by the pandemic have been removed.
In the last financial year, we have purchased 6 new chemotherapy chairs for the Beacon Centre Day
Unit and those previously purchased have been moved to the new unit at Wellington Hospitsl.
A Vital Signs monitor has been purchased which helps the medical team assess patient's fitness to
undergo treath)ent.
A variety of equipment has been purchased for the Mdusa room which is used by the Consultants
to revi¢w paticnts, treatment, Sound proofin8 has been made to the Consulting Roorns in the
Beacon Centre to ensure patient privacy.
A new Ambulatory Room has been established on Ward 9 and the Group have funded the
equipment and furniture required.
The NHS Trust had one pool car. To ensure the haernatology nurses had transport for the clinics at
Bridgwater and Wellington th¢ MLGS is sponsoring a pool car for that specific purpose. It is hoped
in the future to provide a clinic at Williton.
The Gmup has received requests to fund additional equipment for the Ambulatory Room. The
bathroom on Ward 9 is now unfit for purpose so funding is requir￿ to create a new wet room. It is
hopeAI to restore the complementary therapy service on Ward 9 once a week.
Funds are held to support these projects and any other project that falls within our constitution to
enable the Taunton and Somerset Foundation Trust to meet the needs of the patients.
I would like to thank the officers and committee members for their C￿ntinUed commitment through
this difficult period.
Trlda Reed
Chairperson

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the beneflt of Patfients In Somerset
TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024
(continued)
Consul¢ant s Report
It has bccn a long time since our last report has been produced and inevitability there has been a
number of updates and changes in the intervening 5 years. Not least thc dcpartment, trust and the
NHS has bccn through a pandemic which has significantly affected the health service and the
charity group sector. In addition, the trust has undergon¢ a m¢rgcr with Yeovil hospital.
In the haematology dcpartment there have been a number of changes in personnel, in fact almost as
many as the number of prime ministers we hav¢ had. Ha¢matology ￿nSultantS Simon Davis, Sarah
Alford and our previous MLGS President Simon Bolam have all retired from clinical duties with
myself taking over the President role of the MLGS. I am pleased to report that we have been able to
successfully replace and recruit into these posts and we welcome our new consultant coll¢agucs:
Olivw Miles was prcviously working at Gloucester. Martin Best and Loredana Mihailescu were
both trainees with us. so it is particularly nice to see them r¢turning as consultants. We also
welcome our newly fvnded roles of Hospital Speciality Trust doctors, Pratima lyer and Desmond
Maitland.
We have also managed to increase the number of CNSS to scvcn to assist with our increasing patient
workload. With th¢ trust merger the CNS roles at the two acute tsusts have been consolidated to one
body with all CNSS covering both sites. Emma Storey has managed a whole maternity leave in
between these updates- many Con￿atUlatIOnS on the birth of her son,
We have also had a number of changes in our administration teams and not least the retirement of
Shirley Bennett. Despite these changes over the years, we have ￿ntInued to strive to improve the
department and outcomes for patients.
As well the personnel the way of working in the department has also radically changed not l¢&st to
Cat￿ for the inevitable increase in pati¢nts ne¢ding our carc but also rather gloriously the new wave
of drugs available which are revolutionizing the way we treat our patients. In this regard we do have
to acknowl¢dg¢ th¢ charity sector such as ours which help provide care to patients but also help
develop these new drugs based on basic scientific and genomic research.
Therefore, l am pleased to report that despite the turbul¢nt ¢conomic background the MLGS
continues to strive thanks of the generosity of the public and of former patients who keep providing
donations. We are in thc happy position to report that we have a surplus which we have been able to
use to good effect. We are funding a car loan deal which is used by our outr¢ach nurses to providc
chemotherapy and supportive m¢dications in the community throughout Somerset and has been
eatly welcomed by patients. This has effectively replaced th¢ old 'Bumble' bus s¢rvice- sadly a
victim of the pandemic. We have also been managed to furnish our haematology day unit he￿ at
Musgrove Park with n¢w stat¢ of thc art specifically designed Chairs. We have funded the
development and furnishing of the ambulatory care service project adjacent to Ward 9. This results
in patients who are receiving intensiv¢ Chall0th￿apy to go home daily rather than a block of 5
weeks stuck in a ward room. In additio￿ funds have been released to fit ward 9 with further
equipm¢nt including a new bladder scanner, cardiac monitoring hardware, a television for the
ambulatory Care room, hand grip patient assessment tool as w¢ll as fillthcr funds cann￿ed for
bathroom conversions and more CAD pumps to deliver ambulatory chemotherapy. We also used

MUSGROVE LEUKAEMIC GROUP SOMERSET
Ralslng funds for the benefit of Patlents In Somerset
TRUSTEES ANNUAL REpoirr FOR THE YEAR ENDED 29 FEBRUARY 2024
(continued)
funding to purchase a dictation syst¢m to enablc L*)￿eSpOndence to be sent promptly to patients
after clinic appoinknents, as we had a significant backlog of correspondence not ablc to be typed up
and thus not getting to our GP coll¢agues and patients. We have also funded renovations to enable
to make the clinic rooms soundproof.
Once agai￿ the haematology d￿artrncnt are overjoyed to have the SUp￿t of the MLGS and we
hope that we can use these funds wisely to improve the care and offer wc can provide to the p¢ople
of Somerset.
Deepak MaDnarl
Consultant Haematolo
FINANCIAL REVIEW
Treasurers Report
Ih
The total raised for the year ended 29 February 2024 amount¢d to £47,814.
th
The total expenditure for the year ended 29 February 2024 is £25,938.
Ih
The totsl raised since forniation as at the 29 of February 2024 is £4,077, l 97.
The year ending February 2024 has seen a continued restricted fimdraising activity. Unfortunately,
this could bcLx)me the nonn going forward, therefore the continued support of our regular
contributors, donors, and friends plus the dedicateAI work of th¢ Trustees and Members is essential
to enable the Group to continue to support projects at Mus8rove Park Hospital.
The Trustees, members and volunteers absorb all their own ¢xpcnscs, so overheads are minimal and
arc currently under l 0/0 of fimds raised.
Thc mus￿0Ve Leukaemic Group Somerset is in a sound financial position because of the large
legacies received in the financial y¢ar cnding 2022 that resulted in the Group's income for that year
being £535,405. The Covid Pandernic prevented projects proceeding at the NHS TTh￿t which has
sultd in the retained funds held. It is not the Trustees intention to hold these monies in reserves.
D¢tail¢d accounts are att￿hed for inspection.

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the benefit of Patlents In Somerset
TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024
(continued)
Reserves Pollcy
Musgrovc Lcukaemic Group Somerset (MLGS) retains reserves, and this document explains our
policy.
In dcfining this policy the Trustees have considerd;
l ) tnLX)me forecasts for future years taking into account the reliability of each source of income and
the potential for securing new incom¢ from alternativ¢ sOU￿¢s.
2) Exp¢nditur¢ forecasts for future years.
3) The need to hold reserves should a medical breakthrough necessitate the urgent purchase of new
equipment.
4) The need to hold reserves to meet our immediate LX)mmitsnents should income levels drastically
fall.
The Group attempts to maintain reserves of approximately £200,￿0, which is represented by c&sh
on short-tenn deposit and in the Group bank accounts. The present level of retained funds results
from several legacies received in the financial year ending 2022, it is not the Trustees intention to
hold these funds as reserves.
The Group believes it is prudent to keep this level of surplus to..
l ) Ensure the Group can maintain its commitsnent to fund research salaries and consumables
for year periods and to be able to so even if incom¢ l¢v¢ls should substantially fall for a
period sufficient to allow alternative arrangements to be made.
2) To provide equipment on urscnt request if the ned should ￿lSe.
3) To act as a buffer against any unforeseen eventuality.
Our levels of reserves are constantly monitored and reviewed both at Group meetings and
Committee meetings.
The present level of Reserves is considered appropriate to enable the Group to meet our
commitments for the financial year ending 2025. Th¢ receipts reccivcd in 2022 h&8 resulted in the
Musgrove Leukaemic Group Somerset being in a strong financial position.
Bernard Reed
HOD. Treasurer.

MUSGROVE LEUK4EMIC GROUP SOMERSET
Raislng funds for the beneflt of Patients ID Somerset
TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024
(continued)
Trustees, annual report
Th¢ Mus8rovc Lcukaemic Group Somerset (MLGS) was fonned in April 1978 by a group of
parents whose children were undergoing treatment for Icukaemia. Due to the limited facilities at
Musgrovc Park Hospital they had to visit hospitals in Southampton and Bristol for trealment,
placing severe strain on the families.
Th¢ Pre￿At Trustecs are a group of people continuing to fundraise to improve the facilities for
leukaemia and lymphoma patients and their families in Somers¢t.
The funds raised by the MLGS are utiliscd to purchases equipment for the wards to improve the
experience of patients whilst undergoing treatment.
The MLGS has now raised over £4 Million, 959/0 of which has/is being made available to Muswve
Park H05Pitals' Hacmatology/Oncology and Children's Unit because all the Tn￿teeS and members
services are voluntary.
The Trustees have approved several new projects to be completed in 2024 that will reduce the
retained funds held.
Th¢ funds are raisa by various means but principally from donations includin8 le8aci¢s,
collections, and other fundraisin8 ¢v¢nts.
Our aim is to continue to raise fimds to improve the hospitsl experience for leukaemia and
lymphoma patients.

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raislng funds for the benefit of Patlents In Somerset
TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024
(continued)
STATEMENT OF TRUSTEES RESPONSIBILrriES
Charity law requires the trustees to prepare financial statements for each financial year which show
a true and fair view of the state of affairs of th¢ charity and its financial activities for that period. In
prcparing those financial statements, the trustees are requireAI to
Select suitable aceA)unting policies and then apply them consistently;
Makc judgements and ￿tiMat¢S that are reasonable and prudent.
Statc whether applicable accounting standards and statements of recomrn¢nded practice
have been followcd, subject to any d￿artU￿ disclosed and explained in the financial
statements. and
Prepare the financial statements on the going concern basis unlcss it is inappropriate to
prcsume that the charity will continue in operational existence.
The Trustees are responsible for keeping proper accounting records which disclose with reasonable
accuracy at any time the financial position of the charity and to enable them to ensure that the
financial statements comply with the Charities Act 2011. They are also responsibl¢ for
safeguarding the assets of th¢ charity and hence for taking reasonable steps for the prevention and
d¢t¢ction of fraud and other irregularities.
DECLARATION
The Trustees declare that they have approved the Trustees, Report.
Signed on behalf of the charity's trustees: 12 tk fu AJ r 2tJl
Trlcla Reed
Chair

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the benefit of Patients in Somerset
Independent Examiner's Report to the Trustees of Musgrove Leukaemic Group Somerset
I report on the accounts of Musgrove Leukaemic Group Somerset for the year ended 29 February
2024 which are set out on pages 10 to 13.
Respeelive responsibilities of trustees and examiner
The charity's trustees are responsible for th¢ preparation of the accounts. The charity's trustees
consider that an audit is not required for this year under section 144 of the Charitics Act 2011 (the
Charities Act) and that an independent examination is nceded.
It is my responsibility to:
examine the accounts under section 145 of the Charities Act.
to follow the procedures laid down in the general Directions given by the Charity
Commissioners (under section 145 (5) (b) of the Charitie5 Act). and
to state whether particular matters have come to my attention.
Bagls of independent examiner's report
My examination was carried out in accordance with the general Directions given by the Charity
Commission, An examination includes a review of the accounting records kept by the charity and a
comparison of the accounts presented with those records. It also includes consideration of any
unusual items or disclosures in the accounts and seeking explanations from you as trustees
concerning any such matters. The procedures undertaken do not provide all the evidence that would
be required in an audit, and consequently no opinion is given as to whether the accounts present a
'true and fair, view and the report is limited to those matters set out in the statement below.
Independent examiner's 8tatemeDt
In connection with my examination, no matter has come to my attention:
i)
which gives me reasonable cause to believe that An. any material respecL the requirements
to keep accounting records in accordance with section 130 of the Charities Act; and
to prepare accounts which accord with the accountAng records and comply with the
accounting requirements of the Charities Act have not been me: or
2)
to which, in my opinion, attention should be drawn in order to enable a prO￿r
underst ding of the accounts to be reached.
Mark Powell
Moore
6 Floor
l¥hitefriars
Lewins Mead
Bristol
BSI 2NT
Date:

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raislng funds for the beneflt of Patlents In Somerset
STATEMENT OF FINANCIALACTIVITIES
FOR THE YEAR ENDED 29 FEBRUARY 2024
Unrestrlcted Restrlcted Total Funds Total Fundj
Funds
Funds
2024
2023
INCOME & EXPENDITURE
Incomlng Resources
Donations, legacies and similar incoming resources..
Donations
10,671
Fund Raising
8,242
Collections
1,558
Covenants & Gift Aid
(including tax recovered)
10,671
8,242
1,558
35,665
6.398
1.388
2,405
2,405
3.299
Investment Inwme:
Bank Interest
24,938
24,938
7,280
TOTAL IIYCOMING RESOURCES
47,814
47,814
54,030
Resources Expended
Note
Direct Charitabl¢ Expenditure 2
Fund Raising and Publicity
Management and
Administration
24.743
209
24,743
209
1,145
986
986
962
TOTAL RESOURCES EXPENDED
25,938
25,938
2,107
NET (OUTYINFLOW OF
RESOURCES FOR THE YEAR
AND MOVEMENT IN FUF4DS
21,876
21,876
51,923
Balance brought forward at
l March 2023
889,393
889093
837,470
BALANCES CARRIED FORWARD
AT 29 FEBRUARY 2024
911,269
911269
889,393
io

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the beneflt of Patients In Somerset
BALANCE SHEET
AS AT 29 FEBRUARY 2024
2024
2023
Note
CURRENT ASSETS
Debtors
Short tenn deposits
Cash at bank and in hand
722
750,000
160,967
587
505,943
384,737
911,689
891,267
CREDITORS: Amounts falling due within one year
420
1,874
TOTAL NET ASSETS
911369
889,393
Funded by:
UNRESTRICTED FUNDS
General Fund
911369
889,393
These accounts approved by the Tn￿teeS on. I x Zo 2 4
Bernard Reed
Treasurer
For and on behalf of the Trustees
Jane Allin
Secretary
11

MUSGROVE LEUKAEMIC GROUP SOMERSET
Ral$lng funds for the benetit of Patients in Somerset
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 29 FEBRUARY 2024
ACCOUNTIIYG POLICIES
Aceounthig basls and standards
The financial statements have been prepared under the historical cost L￿nvention and
in accordance with applicable accounting standards. th¢ Clwities SORP (FRS102)
(Acwunting and Reporting by Charities) and comply with the Chariti¢s (Accounts
and Reports) Regulations 2008 ISSU￿ under the Charities Act 2011.
b)
Voluntary Income
Voluntary income is received from a number of sources, including donations,
collections and other fvnd raising Cvcnts. Such income is included in ￿11 in the
income and expenditure account when received.
Restricted And Unrestricted Funds
Where appropriate, the accounts distinguish between restricted and unrestricted
funds. The forn]er are received from donors and are subject to restrictions on the
purpose for which they may be used. Unrestricted fvnds are those where there are
no externally imposed r¢strictions which the charity may use at its discretion to
achieve its objectives.
In the opinion of the Officers the Charity does not operate any restricted funds.
d)
Short Term Deposlts
Short tem] deposits represent monies placed on d¢posit with National Westminster
Bank Treasury Rcscrve Centre.
Bank Interest
Bank Interest is cr￿lted to the income and expenditure ac￿Unt when received.
Covenants
Covenants are credited to the incom¢ and expenditure account when received.
Provision is made for recoverable income tax arising from the LX)venants.
12

MUSGROVE LEUKAEMIC GROUP SOMERSET
Ralslng funds for the benefit of PAtlents in Somerset
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 29 FEBRUARY 2024
(Continued)
Taxatlon
Musgrove Leukaemic Group Somerset is a regist¢red charity and the results of its
nonnal activities are not liable to corporation tax.
Unregtrl¢ted Restricted Total Funds Total Funds
Funds
Funds
2024
2023
DIRECT CHARITABLE EXPENDITURE
(Amounts payable in furtherance
of the Charities objects):
Clinical unit grants
Complimentary medicine grants
Chemotherapy pool car ￿ant
19,259
19,259
1.454
(309)
5,484
5,484
24.743
24,743
1,145
The above grants were made in support of Musgrove Park Hospital in Taunton.
FUND RAISING AND PUBLICITY
Fund raising costs
Publications
209
209
209
209
13

MUSGROVE LEUKAEMIC GROUP SOMERSET
Ralslng funds for the benefit of Patlents In Somerset
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 29 FEBRUARY 2024
(Continued)
Unrestrleted Restricted Total Funds Total Funds
Funds
Funds
2024
2023
MANAGEMENT AND
ADMINISTRATION OF CHARITY
Public liability insurance
Ind¢p¢nd¢nt examiners fees
566
420
566
420
542
420
986
986
962
DEBTORS
Income tax recoverable
722
587
CREDITORS: Amounts falllng due wlthlD one year
Accountancy accnwl
Clinical unit ￿antS accrual
420
420
1,454
420
1,874
Balance Net movement Balance
1.3.23
funds
29.224
uNREsTRI￿ED FUNDS
General Fund
889.393
21,876
911,269
14